Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Casdin Capital, LLC
Form 13F · Q2 2026

Casdin Capital, LLC

CIK 1534261申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$20.0亿
申報組合市值
43
持倉數量
12
Quarters on record
Top 50
持倉數量

Casdin Capital, LLC——持倉

共 43 個持倉中的前 43 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1RVMD Revolution Medicines Inc2.6M+0.0%$4.8亿24.2%
2RLAY Relay Therapeutics Inc16.0M+11.2%$3.0亿15.0%
3WGS Genedx Holdings Corp3.7M+23.3%$2.5亿12.7%
4BIOLIFE SOLUTIONS INC Biolife Solutions Inc4.7M−21.9%$1.3亿6.6%
5ILMN Illumina Inc530,000+0.0%$9319万4.7%
6LAB Standard Biotools Inc88.8M+0.0%$7304万3.7%
7GPCR Structure Therapeutics Inc1.2M+0.0%$6306万3.2%
8DNLI Denali Therapeutics Inc2.0M+11.1%$5260万2.6%
9NGNE Neurogene Inc1.5M+8.8%$4860万2.4%
10BEAM Beam Therapeutics Inc1.4M+0.0%$4633万2.3%
11TXG 10X Genomics Inc1.1M−53.8%$4026万2.0%
12SRRK Scholar Rock Hldg Corp665,000+90.0%$3658万1.8%
13PSNL Personalis Inc2.5M+59.4%$3417万1.7%
14GRAL Grail Inc480,000+108.7%$3277万1.6%
15GH Guardant Health Inc185,000−41.3%$2776万1.4%
16MAZE Maze Therapeutics Inc843,857+11.2%$2518万1.3%
17HIMS Hims & Hers Health Inc700,000+0.0%$2427万1.2%
18ALNY Alnylam Pharmaceuticals Inc75,000+0.0%$2258万1.1%
19TSHA Taysha Gene Therapies Inc3.2M+0.0%$2213万1.1%
20AGMB Agomab Therapeutics Nv1.6M+0.0%$2012万1.0%
21SEPN Septerna Inc553,268+0.0%$1853万0.9%
22PBLS Parabilis Medicines Inc645,690—$1767万0.9%
23SION Sionna Therapeutics Inc400,000—$1760万0.9%
24VCYT Veracyte Inc276,308+0.0%$1623万0.8%
25ANL Adlai Nortye Ltd1.2M+132.1%$1438万0.7%
26PRME Prime Medicine Inc3.2M+0.0%$1169万0.6%
27ABSI Absci Corporation973,260+0.0%$1128万0.6%
28DGX Quest Diagnostics Inc50,000+0.0%$1060万0.5%
29SRPT Sarepta Therapeutics Inc470,000—$845万0.4%
30QURE Uniqure Nv150,000—$691万0.3%
31NTLA Intellia Therapeutics Inc355,000+0.0%$601万0.3%
32MRNA Moderna Inc75,000+0.0%$525万0.3%
33IRON Disc Medicine Inc65,000+0.0%$475万0.2%
34GLUE Monte Rosa Therapeutics Inc186,014+0.0%$450万0.2%
35IPSC Century Therapeutics Inc1.2M+0.0%$301万0.2%
36CTNM Contineum Therapeutics Inc148,333+0.0%$243万0.1%
37BBOT Bridgebio Oncology Therapeut282,312+0.0%$215万0.1%
38EDIT Editas Medicine Inc445,000—$144万0.1%
39PACB Pacific Biosciences Calif In723,767+0.0%$122万0.1%
40KARD Kardigan Inc50,000—$119万0.1%
41RXRX Recursion Pharmaceuticals In165,323+0.0%$61万0.0%
42DNA Ginkgo Bioworks Holdings Inc36,493+0.0%$36万0.0%
43TNYA Tenaya Therapeutics Inc361,969+0.0%$27万0.0%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。